Summary:
«Devices that monitor blood oxygen levels in the hospital and at home need to be more carefully regulated, a Food and Drug Administration advisory panel indicated at a meeting Tuesday.»
«The devices are everywhere in healthcare settings, and people regularly purchase them for at-home use. But research over the past few decades has steadily shown that they don’t work as well for people with darker skin tones — a disparity that became even more critical during the covid pandemic. The FDA issued an alert saying that the devices have “limitations” in 2021.»
Article written by NICOLE WETSMAN
03|11|2022
Source:
The Verge
https://www.theverge.com/2022/11/3/23438808/blood-oxygen-monitor-fda-bias-regulation